Walleye Capital’s Dynavax Technologies DVAX Stock Holding History

Walleye Capital’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,900	Closed	-$28.8K	–	4684
2025 Q3	$28.8K	Buy	+2,900	New	+$30.2K	﹤0.01%	4150
2025 Q1	–	Sell	-10,300	Closed	-$132K	–	4439
2024 Q4	$132K	Sell	10,300 -4,600	-31%	-$55.6K	﹤0.01%	4001
2024 Q3	$166K	Buy	14,900 +10,000	+204%	+$110K	﹤0.01%	4131
2024 Q2	$55K	Buy	4,900 +2,500	+104%	+$29.1K	﹤0.01%	4903
2024 Q1	$29.8K	Buy	+2,400	New	+$31.3K	﹤0.01%	4823
2023 Q1	–	Sell	-21,500	Closed	-$229K	–	4025
2022 Q4	$229K	Buy	+21,500	New	+$250K	﹤0.01%	1951

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Capital's DVAX Position: Q1 2026 in Review

Walleye Capital sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 101,970 shares — an estimated $1.57M sold.

Walleye Capital first reported a position in DVAX in Q2 2019 and held it in 8 quarters. The position peaked at $3.46M in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Walleye Capital reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Walleye Capital sold 101,970 Dynavax Technologies shares in Q1 2026, an estimated $1.57M.
Walleye Capital first reported a position in Dynavax Technologies in Q2 2019 and held it in 8 quarters.
Walleye Capital's Dynavax Technologies position peaked at $3.46M in Q1 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.